Treatment of Adriamycin, a type of chemotherapy, may be linked with breast cancer in Hodgkin lymphoma survivors, a study showed. Survivors of Hodgkin lymphoma who have received Adriamycin (doxorubicin ...

After the publication of the 10-year survival data from Milan on the adjuvant use of the block sequential regimen consisting of four cycles of adriamycin followed by eight cycles of intravenous CMF, ...

Doxorubicin (Adriamycin (50 mg)) is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.It works by killing cancer cells. The information provided on this page is ...

The appropriate assay time for duodenal crypt-cell survival following whole-body X irradiation and adriamycin treatment of C3H mice was evaluated by estimating the X-irradiation D 0 and the 10-clone ...

Effect of circulating tumor cells distribution in treatment naive and treated patients with advance stage breast cancer on disease burden. Amelioration of acute radiation dermatitis in patients with ...

The validity of chemotherapy drug Adriamycin has been called into question, as a new study shows breast cancer survival rates are almost unchanged by its usage. Subscribe today to access over 6,000 ...

Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up. This is an ASCO Meeting Abstract ...

Kristie L. Kahl: Can discuss some common side effects that we see with current standards of care for triple-negative breast cancer treatment? Dr. Ogori Kalu: The current standard treatment includes ...

Radiation Research, Vol. 119, No. 1 (Jul., 1989), pp. 88-100 (13 pages) Adriamycin-resistant variants derived from V79 Chinese hamster cells were examined for their radiation response properties. A ...

This trial looked at a combination of bortezomib, adriamycin and dexamethasone (PAD) for myeloma. It was for people who had not had any other treatment for their myeloma. The trial was open for people ...

AMORY – In the years since she was 45, not only has Brenda Boozer earned the designation of being a breast cancer survivor, she has used the experience as motivation to defeat Stage 3 lymphoma and ...